Ga-DOTA-TATE not checked

Novartis · AAA501

FollowEvery change as it happens, and a Monday email
Stage
in the US
Next date
Phase 1/2 trial completes
Trials
2 active
4 in total · 3 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“2 MBq/kg of body weight (0.054 mCi/kg), with a minimum dose of 100 MBq (2.7 mCi) and maximum dose of 200 MBq (5.4 mCi)”In the company’s words, NCT05142696 on ClinicalTrials.gov
Tested for
Extensive Stage Small Cell Lung Cancer, Glioblastoma
Main trialPhase 1/2
“This study aims to establish a safe and well tolerated dose of \[177Lu\]Lu-DOTA-TATE in combination with carboplatin, etoposide and atezolizumab in this setting and to assess preliminary efficacy of this combination treatment versus the combination of carboplatin, etoposide, and atezolizumab.The study will be essential to assess a new potential therapeutic option in participants with this aggressive cancer type.”In the company’s words, NCT05142696 on ClinicalTrials.gov
Other names
AAA501

Other drugs for Extensive Stage Small Cell Lung Cancer

All 118 drugs for Extensive Stage Small Cell Lung Cancer

Coming up1

Changes2

Last 90 days

Trials4

TrialPhaseCompletesWhat it tests
Phase 1/2Active, not recruiting 7 Mar 2028 A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
Phase 1Active, not recruiting 3 Dec 2025 A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
Phase 3Completed 27 Dec 2024 A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan
Phase 1Terminated 16 Oct 2026 NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Ga-DOTA-TATE

Following is part of Solo: you see every change to Ga-DOTA-TATE the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in